A Human Application Study to Evaluate the Non-comedogenicity of Curecode Neuromide Ampoule in Acne-prone Skin

A Human Application Study on the Non-comedogenicity of "Curecode Neuromide Ampoule"

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011494

Enrollment

Registered

2026-01-20

Start date

2024-12-09

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Cosmetic product) : Participants applied the Curecode Neuromide Ampoule repeatedly to designated skin areas for a defined period. Changes in follicle and comedone formation were evaluated at th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult males and females aged 20 to 40 years with acne-prone skin. Participants with a Global Acne Grading System (GAGS) score between 1 and 30 who understood the study purpose and procedures and voluntarily provided written informed consent were included.

Exclusion criteria

Exclusion criteria: Participants with skin diseases, wounds, infections, or severe inflammation at the test sites; those who had recently used dermatologic treatments or medications that could affect study outcomes; pregnant or breastfeeding women; individuals unlikely to comply with the study procedures; and those deemed unsuitable for participation by the investigator were excluded.

Design outcomes

Primary

Measure	Time frame
Change in follicle-to-comedone ratio at the test product application site compared with baseline and control sites	—

Secondary

Measure	Time frame
Incidence of skin adverse reactions following use of the test product during the study period	—

Countries

Korea, Republic of

Contacts

Public ContactMin Youl Chang

SKINMED

mychang195@gmail.com+82-70-5118-8420

Outcome results